Denali Therapeutics: Navigating Through Recent Setbacks
Source: SeekingAlpha
2025-06-26 14:36:06 ET
Today, I am putting Denali Therapeutics Inc. ( DNLI ) in the spotlight for the first time in 2025. My last article on this intriguing but complex clinical stage biotech concern was in August 2024. I concluded that piece by saying was it was probably too early to make an investment in Denali, but it was an interesting story to keep an eye on....
Read the full article on Seeking Alpha
For further details see:
Denali Therapeutics: Navigating Through Recent Setbacks
Denali Therapeutics Inc.
NASDAQ: DNLI
DNLI Trading
-1.27% G/L:
$20.25 Last:
349,466 Volume:
$20.91 Open:
DNLI Latest News
February 26, 2026 04:01:00 pm
Denali Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
February 19, 2026 08:30:00 am
Drug-Delivery Breakthroughs, Cross-Indication Research Accelerate New Momentum in CNS and Oncology Development
DNLI Stock Data
$3,127,833,066
136,297,507
0.26%
87
N/A
Biotechnology & Life Sciences
Healthcare
US
South San Francisco
